47. Matsui TK, Matsubayashi M, Sakaguchi YM, Hayashi RK, Zheng C, Sugie K, Hasegawa M, Nakagawa T, Mori E. Six-month cultured cerebral organoids from human ES cells contain matured neural cells. Neurosci Lett. 670:75-82, 2018

48. Tanaka N, Torimoto K, Asakawa I, Miyake M, Anai S, Nakai Y, Fujii T, Hasegawa M, Fujimoto K. Comparison of chronological changes in urinary function in patients who underwent low-dose-rate brachytherapy for prostate cancer-A randomized controlled trial of alpha-1 adrenoceptor antagonist alone versus combination with cyclooxygenase-2 inhibitor. Brachytherapy. 17(3):537-543, 2018

49. Yoshimine T, Fujitani N, Ikeguchi T, Iwami H, Matsuda R, Tamamoto T, Morimoto Y, Hasegawa M. Is the linear-quadratic model appropriate for stereotactic irradiation of metastatic brain tumors? J Nara Med Assoc. 69 (1,2,3): 9-15, 2018

50. Ishibashi N, Soejima T, Kawaguchi H, Akiba T, Hasegawa M, Isobe K, Ito H, Imai M, Ejima Y, Hata M, Sasai K, Shimoda E, Maebayashi T, Oguchi M, Akimoto T; Japanese Radiation Oncology Study Group. National survey of myeloablative total body irradiation prior to hematopoietic stem cell transplantation in Japan: survey of the Japanese Radiation Oncology Study Group (JROSG). J Radiat Res. 59(4):477-483, 2018

51. Nakamura N, Hojo H, Inoue K, Hotta K, Zenda S, Baba H, Onozawa M, Motegi A, Nakamura M, Kibe Y, Akimoto T. Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer. J Radiat Res. 1;59(4):456-461, 2018

52. Nakagawa K, Akahori T, Nishiwada S, Nagai M, Nakamura K, Tanaka T, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Ikeda N, Sho M. Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma. Langenbecks Arch Surg. 403(6):693-700, 2018

53. Nakagawa Y, Kajihara A, Takahashi A, Murata AS, Matsubayashi M, Ito SS, Ota I, Nakagawa T, Hasegawa M, Kirita T, Ohnishi T, Mori E. BRCA2 protects mammalian cells from heat shock. Int J Hyperthermia. 34(6):795-801, 2018

54. Nakai Y, Tanaka N, Anai S, Miyake M, Asakawa I, Morizawa Y, Hori S, Torimoto K, Fujii T, Hasegawa M, Fujimoto K. Quality of life worsened the most severely in patients immediately after intensity-modulated radiotherapy for prostate cancer. Res Rep Urol. 10:169-180, 2018

55. Kawaguchi T, Sawabata N, Nakai T, Miura S, Kawai N, Yasukawa M, Tojo T, Ohbayashi C, Taniguchi S. Clinical and pathological characteristics of surgically resected intrapulmonary lymph nodes: Can they be differentiated from other malignant nodules? Respir Investig. 56(6):473-479, 2018

56. Onishi K, Tanaka N, Miyake M, Nakai Y, Anai S, Torimoto K, Yamaki K, Asakawa I, Hasegawa M, Fujii T, Konishi N, Fujimoto K. Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer. Clin Transl Radiat Oncol. 14:51-58, 2018